These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 8065408)
1. Risks and benefits of antiarrhythmic therapy. Roden DM N Engl J Med; 1994 Sep; 331(12):785-91. PubMed ID: 8065408 [No Abstract] [Full Text] [Related]
2. [The pro-arrhythmic effects of anti-arrhythmia agents]. Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949 [TBL] [Abstract][Full Text] [Related]
3. Drugs, QT interval abnormalities and ventricular arrhythmias. Thomas SH Adverse Drug React Toxicol Rev; 1994; 13(2):77-102. PubMed ID: 7918900 [No Abstract] [Full Text] [Related]
4. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade. Skanes AC; Morton BC; Green MS; Tang AS Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970 [TBL] [Abstract][Full Text] [Related]
5. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. Mason JW N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150 [TBL] [Abstract][Full Text] [Related]
6. What have clinical trials taught us about proarrhythmia? Skanes AC; Green MS Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725 [TBL] [Abstract][Full Text] [Related]
7. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes. Shah SA; Kluger J; White CM Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083 [TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study]. Meinertz T; Zehender M; Hohnloser SH Z Kardiol; 1992; 81 Suppl 4():145-9. PubMed ID: 1290291 [TBL] [Abstract][Full Text] [Related]
9. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine. Lin JC; Quasny HA Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570 [TBL] [Abstract][Full Text] [Related]
10. Is there a need for new antiarrhythmic drugs? Roden DM Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158 [TBL] [Abstract][Full Text] [Related]